{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:48:57Z","timestamp":1771066137252,"version":"3.50.1"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12640-022-00477-8","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T07:02:32Z","timestamp":1643180552000},"page":"646-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy"],"prefix":"10.1007","volume":"40","author":[{"given":"Piyush","family":"Madaan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-7708","authenticated-orcid":false,"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayush","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satvinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A. H.","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam Md","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Abdel-Daim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamad Ghaleb","family":"Dailah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Khalid","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1254\/jjp.78.113","volume":"78","author":"MP Abbracchio","year":"1998","unstructured":"Abbracchio MP, Burnstock G (1998) Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78:113\u2013145. https:\/\/doi.org\/10.1254\/jjp.78.113","journal-title":"Jpn J Pharmacol"},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems JM et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281\u2013341. https:\/\/doi.org\/10.1124\/pr.58.3.3","journal-title":"Pharmacol Rev"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1152\/jn.1994.72.2.684","volume":"72","author":"SC Ahlgren","year":"1994","unstructured":"Ahlgren SC, Levine JD (1994) Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 72:684\u2013692. https:\/\/doi.org\/10.1152\/jn.1994.72.2.684","journal-title":"J Neurophysiol"},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/alcalc\/35.5.452","volume":"35","author":"B Ahluwalia","year":"2000","unstructured":"Ahluwalia B, Ahmad S, Adeyiga O, Wesley B, Rajguru S (2000) Low levels of ethanol stimulate and high levels decrease phosphorylation in microtubule-associated proteins in rat brain: an in vitro study. Alcohol Alcohol 35:452\u2013457. https:\/\/doi.org\/10.1093\/alcalc\/35.5.452","journal-title":"Alcohol Alcohol"},{"key":"477_CR5","doi-asserted-by":"publisher","unstructured":"Akbar M, Egli M, Cho YE, Song BJ, Noronha A (2018) Medications for alcohol use disorders: an overview. Pharmacol Ther 185:64\u201385. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.11.007","DOI":"10.1016\/j.pharmthera.2017.11.007"},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0306-4522(02)00009-X","volume":"111","author":"KO Aley","year":"2002","unstructured":"Aley KO, Levine JD (2002) Different peripheral mechanisms mediate enhanced nociception in metabolic\/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111:389\u2013397. https:\/\/doi.org\/10.1016\/S0306-4522(02)00009-X","journal-title":"Neuroscience"},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0361-9230(93)90278-J","volume":"30","author":"WM Al-Ghoul","year":"1993","unstructured":"Al-Ghoul WM, Volsi GL, Weinberg RJ, Rustioni A (1993) Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res Bull 30:453\u2013459. https:\/\/doi.org\/10.1016\/0361-9230(93)90278-J","journal-title":"Brain Res Bull"},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/alcalc\/36.3.271","volume":"36","author":"A Ammendola","year":"2001","unstructured":"Ammendola A, Tata MR, Aurilio C, Ciccone G, Gemini D, Ammendola E, Ugolini G, Argenzio F (2001) Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcohol Alcohol 36:271\u2013275. https:\/\/doi.org\/10.1093\/alcalc\/36.3.271","journal-title":"Alcohol Alcohol"},{"key":"477_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/ijms20010155","volume":"20","author":"M Arribas-Bl\u00e1zquez","year":"2019","unstructured":"Arribas-Bl\u00e1zquez M, Olivos-Or\u00e9 LA, Barahona MV et al (2019) Overexpression of P2X3 and P2X7 receptors and TRPV1 channels in adrenomedullary chromaffin cells in a rat model of neuropathic pain. Int J Mol Sci 20:155. https:\/\/doi.org\/10.3390\/ijms20010155","journal-title":"Int J Mol Sci"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1523\/JNEUROSCI.17-14-05297.1997","volume":"17","author":"R Bardoni","year":"1997","unstructured":"Bardoni R, Goldstein PA, Lee CJ, Gu JG, MacDermott AB (1997) ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci 17:5297\u20135304. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-14-05297.1997","journal-title":"J Neurosci"},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbamem.2012.01.002","volume":"1828","author":"A Baroja-Mazo","year":"2013","unstructured":"Baroja-Mazo A, Barber\u00e0-Cremades M, Pelegr\u00edn P (2013) The participation of plasma membrane hemichannels to purinergic signaling. BiochimBiophys Acta 1828:79\u201393. https:\/\/doi.org\/10.1016\/j.bbamem.2012.01.002","journal-title":"BiochimBiophys Acta"},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1074\/jbc.M412265200","volume":"280","author":"NP Barrera","year":"2005","unstructured":"Barrera NP, Ormond SJ, Henderson RM, Murrell-Lagnado RD, Edwardson JM (2005) Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J Biol Chem 280:10759\u201310765. https:\/\/doi.org\/10.1074\/jbc.M412265200","journal-title":"J Biol Chem"},{"key":"477_CR13","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.3390\/ijms21114041","volume":"21","author":"R Bautista-P\u00e9rez","year":"2020","unstructured":"Bautista-P\u00e9rez R, P\u00e9rez-M\u00e9ndez O, Cano-Mart\u00ednez A et al (2020) The role of P2X7 purinergic receptors in the renal inflammation associated with angiotensin II-induced hypertension. Int J Mol Sci 21:4041. https:\/\/doi.org\/10.3390\/ijms21114041","journal-title":"Int J Mol Sci"},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1447-y","volume":"16","author":"L Becquet","year":"2019","unstructured":"Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV (2019) Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. J Neuroinflammation 16:1\u201312. https:\/\/doi.org\/10.1186\/s12974-019-1447-y","journal-title":"J Neuroinflammation"},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874467213666200512114943","volume":"14","author":"T Behl","year":"2020","unstructured":"Behl T, Yadav HN, Sharma PL (2020) Alcoholic Neuropathy: Involvement Of Multifaceted Signalling Mechanisms. Curr Mol Pharmacol 14:2\u201310. https:\/\/doi.org\/10.2174\/1874467213666200512114943","journal-title":"Curr Mol Pharmacol"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1523\/JNEUROSCI.17-13-04956.1997","volume":"17","author":"K Biber","year":"1997","unstructured":"Biber K, Klotz KN, Berger M, Gebicke-H\u00e4rter PJ, van Calker D (1997) Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 17:4956\u20134964. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-13-04956.1997","journal-title":"J Neurosci"},{"key":"477_CR17","first-page":"46","volume":"7","author":"M Bihamta","year":"2017","unstructured":"Bihamta M, Hosseini A, Ghorbani A, Boroushaki MT (2017) Protective effect of pomegranate seed oil against H2O2-induced oxidative stress in cardiomyocytes. Avicenna J Phytomed 7:46","journal-title":"Avicenna J Phytomed"},{"key":"477_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3959(00)00470-X","volume":"92","author":"S Bingham","year":"2001","unstructured":"Bingham S, Davey PT, Babbs AJ et al (2001) Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92:81\u201390. https:\/\/doi.org\/10.1016\/S0304-3959(00)00470-X","journal-title":"Pain"},{"key":"477_CR19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of adenosine receptors: the state of the art. Physiol Rev 98:1591\u20131625. https:\/\/doi.org\/10.1152\/physrev.00049.2017","journal-title":"Physiol Rev"},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","volume":"49","author":"SL Borgland","year":"2006","unstructured":"Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589\u2013601. https:\/\/doi.org\/10.1016\/j.neuron.2006.01.016","journal-title":"Neuron"},{"key":"477_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mus.880020208","volume":"2","author":"EP Bosch","year":"1979","unstructured":"Bosch EP, Pelham RW, Rasool CG et al (1979) Animal models of alcoholic neuropathy: morphologic, electrophysiologic, and biochemical findings. Muscle Nerve 2:133\u2013144. https:\/\/doi.org\/10.1002\/mus.880020208","journal-title":"Muscle Nerve"},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ddr.1197","volume":"53","author":"SG Brown","year":"2001","unstructured":"Brown SG, Kim YC, Kim SA, Jacobson KA, Burnstock G, King BF (2001) Actions of a series of PPADS analogs at P2X1 and P2X3 receptors. Drug Dev Res 53:281\u2013291. https:\/\/doi.org\/10.1002\/ddr.1197","journal-title":"Drug Dev Res"},{"key":"477_CR23","doi-asserted-by":"publisher","unstructured":"Burnstock G (1976) Purinergic receptors. J Theor Biol 62:491\u2013503. https:\/\/doi.org\/10.1016\/0022-5193(76)90133-8","DOI":"10.1016\/0022-5193(76)90133-8"},{"key":"477_CR24","unstructured":"Burnstock GA (1978) A basis for distinguishing two types of purinergic receptor. Cell Membrane Receptors for Drugs and Hormone: A Multidisciplinary Approach 107\u2013118"},{"key":"477_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.pharmthera.2005.08.013","volume":"110","author":"G Burnstock","year":"2006","unstructured":"Burnstock G (2006a) Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 110:433\u2013454. https:\/\/doi.org\/10.1016\/j.pharmthera.2005.08.013","journal-title":"Pharmacol Ther"},{"key":"477_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/pr.58.1.5","volume":"58","author":"G Burnstock","year":"2006","unstructured":"Burnstock G (2006b) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58\u201386. https:\/\/doi.org\/10.1124\/pr.58.1.5","journal-title":"Pharmacol Rev"},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"G Burnstock","year":"2007","unstructured":"Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659\u2013797. https:\/\/doi.org\/10.1152\/physrev.00043.2006","journal-title":"Physiol Rev"},{"key":"477_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008a) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575\u2013590. https:\/\/doi.org\/10.1038\/nrd2605","journal-title":"Nat Rev Drug Discov"},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1113\/jphysiol.2008.155903","volume":"586","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008b) Unresolved issues and controversies in purinergic signalling. J Physiol 586:3307\u20133312. https:\/\/doi.org\/10.1113\/jphysiol.2008.155903","journal-title":"J Physiol"},{"key":"477_CR30","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-5-69","volume":"5","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009a) Purinergic mechanosensory transduction and visceral pain. Mol Pain 5:1744\u20138069. https:\/\/doi.org\/10.1186\/1744-8069-5-69","journal-title":"Mol Pain"},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2174\/138161209788186335","volume":"15","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009b) Purinergic receptors and pain. Curr Pharm Des 15:1717\u20131735. https:\/\/doi.org\/10.2174\/138161209788186335","journal-title":"Curr Pharm Des"},{"key":"477_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic Signalling: Therapeutic Developments Front Pharmacol 8:1\u201355. https:\/\/doi.org\/10.3389\/fphar.2017.00661","journal-title":"Purinergic Signalling: Therapeutic Developments Front Pharmacol"},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","volume":"240","author":"G Burnstock","year":"2004","unstructured":"Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31\u2013304","journal-title":"Int Rev Cytol"},{"key":"477_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.11","volume":"1","author":"G Burnstock","year":"2010","unstructured":"Burnstock G, Verkhratsky A (2010) Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1:e9. https:\/\/doi.org\/10.1038\/cddis.2009.11","journal-title":"Cell Death Dis"},{"key":"477_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2014.03.043","volume":"269","author":"RJ Cady","year":"2014","unstructured":"Cady RJ, Denson JE, Sullivan LQ, Durham PL (2014) Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization. Neuroscience 269:79\u201392. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.03.043","journal-title":"Neuroscience"},{"key":"477_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11302-008-9110-6","volume":"5","author":"WA Carroll","year":"2009","unstructured":"Carroll WA, Donnelly-Roberts D, Jarvis MF (2009) Selective P2X 7 receptor antagonists for chronic inflammation and pain. Purinergic Signal 5:63\u201373. https:\/\/doi.org\/10.1007\/s11302-008-9110-6","journal-title":"Purinergic Signal"},{"key":"477_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","volume":"114","author":"IP Chessell","year":"2005","unstructured":"Chessell IP, Hatcher JP, Bountra C et al (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386\u2013396. https:\/\/doi.org\/10.1016\/j.pain.2005.01.002","journal-title":"Pain"},{"key":"477_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-52531-9","volume":"9","author":"R Chess-Williams","year":"2019","unstructured":"Chess-Williams R, Sellers DJ, Brierley SM, Grundy D, Grundy L (2019) Purinergic receptor mediated calcium signalling in urothelial cells. Sci Rep 9:1\u201310. https:\/\/doi.org\/10.1038\/s41598-019-52531-9","journal-title":"Sci Rep"},{"key":"477_CR39","doi-asserted-by":"publisher","unstructured":"Chiechio S, Nicoletti F (2012) Metabotropic glutamate receptors and the control of chronic pain. Curr Opin Pharmacol 12:28\u201334. https:\/\/doi.org\/10.1016\/j.coph.2011.10.010","DOI":"10.1016\/j.coph.2011.10.010"},{"key":"477_CR40","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.2174\/138161210793292483","volume":"16","author":"LC Chiou","year":"2010","unstructured":"Chiou LC, Lee HJ, Ho YC et al (2010) Orexins\/hypocretins: pain regulation and cellular actions. Curr Pharm Des 16:3089\u20133100. https:\/\/doi.org\/10.2174\/138161210793292483","journal-title":"Curr Pharm Des"},{"key":"477_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2125.2011.04111.x","volume":"73","author":"K Chopra","year":"2012","unstructured":"Chopra K, Tiwari V (2012) Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol 73:348\u2013362. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04111.x","journal-title":"Br J Clin Pharmacol"},{"key":"477_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2018.10.047","volume":"690","author":"C Coddou","year":"2019","unstructured":"Coddou C, Sandoval R, Hevia MJ, Stojilkovic SS (2019) Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor. Neurosci Lett 690:219\u2013224. https:\/\/doi.org\/10.1016\/j.neulet.2018.10.047","journal-title":"Neurosci Lett"},{"key":"477_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nature04223","volume":"438","author":"JA Coull","year":"2005","unstructured":"Coull JA, Beggs S, Boudreau D et al (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017\u20131021. https:\/\/doi.org\/10.1038\/nature04223","journal-title":"Nature"},{"key":"477_CR44","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.3748\/wjg.v27.i44.7582","volume":"27","author":"A Couvineau","year":"2021","unstructured":"Couvineau A, Voisin T, Nicole P, Gratio V, Blais A (2021) Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 27:7582. https:\/\/doi.org\/10.3748\/wjg.v27.i44.7582","journal-title":"World J Gastroenterol"},{"key":"477_CR45","doi-asserted-by":"publisher","unstructured":"Cristino L, Imperatore R, Palomba L, Di Marzo V (2017) The endocannabinoid system in leptin-driven changes of orexinergic signaling under physiological and pathological conditions. In: Melis M (ed) Endocannabinoids and Lipid Mediators in Brain Functions. Springer, Cham, pp 1\u201326.\u00a0https:\/\/doi.org\/10.1007\/978-3-319-57371-7_1","DOI":"10.1007\/978-3-319-57371-7_1"},{"key":"477_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12584","volume":"5","author":"J Davies","year":"2015","unstructured":"Davies J, Chen J, Pink R, Carter D, Saunders N, Sotiriadis G, Bai B, Pan Y, Howlett D, Payne A, Randeva H, Karteris E (2015) Orexin receptors exert a neuroprotective effect in Alzheimer\u2019s disease (AD) via heterodimerization with GPR103. Sci Rep 5:1\u201312. https:\/\/doi.org\/10.1038\/srep12584","journal-title":"Sci Rep"},{"key":"477_CR47","doi-asserted-by":"publisher","unstructured":"De Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett F2, Frankel WN\u00a0et al (1998)\u00a0The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 95:322\u2013327.\u00a0https:\/\/doi.org\/10.1073\/pnas.95.1.322","DOI":"10.1073\/pnas.95.1.322"},{"key":"477_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jnr.20563","volume":"81","author":"IM Depaz","year":"2005","unstructured":"Depaz IM, de Las HR, Kroon PA, Wilce PA (2005) Changes in neuronal protein 22 expression and cytoskeletal association in the alcohol-dependent and withdrawn rat brain. J Neurosci Res 81:253\u2013260. https:\/\/doi.org\/10.1002\/jnr.20563","journal-title":"J Neurosci Res"},{"key":"477_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/ADM.0b013e3181bd893f","volume":"4","author":"R Dhaher","year":"2010","unstructured":"Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA (2010) The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J Addict Med 4:153. https:\/\/doi.org\/10.1097\/ADM.0b013e3181bd893f","journal-title":"J Addict Med"},{"key":"477_CR50","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1046\/j.0953-816x.2001.01614.x","volume":"13","author":"OA Dina","year":"2001","unstructured":"Dina OA, Aley KO, Isenberg W, Messing RO, Levine JD (2001) Sex hormones regulate the contribution of PKC\u03b5 and PKA signalling in inflammatory pain in the rat. Eur J Neurosci 13:2227\u20132233. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01614.x","journal-title":"Eur J Neurosci"},{"key":"477_CR51","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1523\/JNEUROSCI.20-22-08614.2000","volume":"20","author":"OA Dina","year":"2000","unstructured":"Dina OA, Barletta J, Chen X, Mutero A, Martin A, Messing RO, Levine JD (2000) Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 20:8614\u20138619. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-22-08614.2000","journal-title":"J Neurosci"},{"key":"477_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neuroscience.2006.11.053","volume":"145","author":"OA Dina","year":"2007","unstructured":"Dina OA, Gear RW, Messing RO, Levine JD (2007) Severity of alcohol-induced painful peripheral neuropathy in female rats: Role of estrogen and protein kinase (A and C\u03b5). Neuroscience 145:350\u2013356. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.11.053","journal-title":"Neuroscience"},{"key":"477_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pain.2005.02.028","volume":"115","author":"OA Dina","year":"2005","unstructured":"Dina OA, Hucho T, Yeh J, Malik-Hall M, Reichling DB, Levine JD (2005) Primary afferent second messenger cascades interact with specific integrin subunits in producing inflammatory hyperalgesia. Pain 115:191\u2013203. https:\/\/doi.org\/10.1016\/j.pain.2005.02.028","journal-title":"Pain"},{"key":"477_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1460-9568.2007.05987.x","volume":"27","author":"OA Dina","year":"2008","unstructured":"Dina OA, Khasar SG, Alessandri-Haber N, Green PG, Messing RO, Levine JD (2008) Alcohol-induced stress in painful alcoholic neuropathy. Eur J Neurosci 27:83\u201392. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05987.x","journal-title":"Eur J Neurosci"},{"key":"477_CR55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1460-9568.2006.04886.x","volume":"24","author":"OA Dina","year":"2006","unstructured":"Dina OA, Messing RO, Levine JD (2006) Ethanol withdrawal induces hyperalgesia mediated by PKC\u03b5. Eur J Neurosci 24:197\u2013204. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04886.x","journal-title":"Eur J Neurosci"},{"key":"477_CR56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"477_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gnh044","volume":"32","author":"G Dorn","year":"2004","unstructured":"Dorn G, Patel S, Wotherspoon G et al (2004) siRNA relieves chronic neuropathic pain. Nucleic Acids Res 32:e49. https:\/\/doi.org\/10.1093\/nar\/gnh044","journal-title":"Nucleic Acids Res"},{"key":"477_CR58","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/ijms22073468","volume":"22","author":"C Dsouza","year":"2021","unstructured":"Dsouza C, Komarova SV (2021) Characterization of Potency of the P2Y13 Receptor Agonists: A Meta-Analysis. Int J Mol Sci 22:3468. https:\/\/doi.org\/10.3390\/ijms22073468","journal-title":"Int J Mol Sci"},{"key":"477_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40139-020-00214-w","volume":"8","author":"I Dudek","year":"2020","unstructured":"Dudek I, Hajduga D, Sie\u0144ko C, Maani A, Sitarz E, Sitarz M, Forma A (2020) Alcohol-Induced Neuropathy in Chronic Alcoholism: Causes, Pathophysiology, Diagnosis, and Treatment Options. CurrPathobiol Rep 8:87\u201397. https:\/\/doi.org\/10.1007\/s40139-020-00214-w","journal-title":"CurrPathobiol Rep"},{"key":"477_CR60","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fnins.2018.00934","volume":"12","author":"ET Dustrude","year":"2018","unstructured":"Dustrude ET, Caliman IF, Bernabe CS, Fitz SD, Grafe LA, Bhatnagar S, Bonaventure P, Johnson PL, Molosh AI, Shekhar A (2018) Orexin depolarizes central amygdala neurons via orexin receptor 1, phospholipase C and sodium-calcium exchanger and modulates conditioned fear. Frontiers Neurosci 12:934. https:\/\/doi.org\/10.3389\/fnins.2018.00934","journal-title":"Frontiers Neurosci"},{"key":"477_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnins.2014.00008","volume":"8","author":"K Etori","year":"2014","unstructured":"Etori K, Saito Y, Tsujino N, Sakurai T (2014) Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep\/wakefulness states in mice. Frontiers Neurosci 8:8. https:\/\/doi.org\/10.3389\/fnins.2014.00008","journal-title":"Frontiers Neurosci"},{"key":"477_CR62","first-page":"178","volume":"48","author":"RJ Evans","year":"1995","unstructured":"Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol 48:178\u2013183","journal-title":"Mol Pharmacol"},{"key":"477_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11302-011-9270-7","volume":"8","author":"RA Felix","year":"2012","unstructured":"Felix RA, Martin S, Pinion S, Crawford DJ (2012) Development of a comprehensive set of P2 receptor pharmacological research compounds. Purinergic Signal 8:101\u2013112. https:\/\/doi.org\/10.1007\/s11302-011-9270-7","journal-title":"Purinergic Signal"},{"key":"477_CR64","doi-asserted-by":"publisher","unstructured":"Ferreira LG, Faria RX, Ferreira NC, Soares-Bezerra RJ (2016) Brilliant blue dyes in daily food: how could purinergic system be affected?. Int J Food Sci.\u00a0https:\/\/doi.org\/10.1155\/2016\/7548498","DOI":"10.1155\/2016\/7548498"},{"key":"477_CR65","first-page":"527","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"477_CR66","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.bjp.0707217","volume":"151","author":"Z Gerevich","year":"2007","unstructured":"Gerevich Z, Zadori Z, M\u00fcller C, Wirkner K, Schr\u00f6der W, Rubini P, Illes P (2007) Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol 151:226\u2013236. https:\/\/doi.org\/10.1038\/sj.bjp.0707217","journal-title":"Br J Pharmacol"},{"key":"477_CR67","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","volume":"452","author":"JR Gever","year":"2006","unstructured":"Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford AP (2006) Pharmacology of P2X channels. Pfl\u00fcgersArchiv 452:513\u2013537. https:\/\/doi.org\/10.1007\/s00424-006-0070-9","journal-title":"Pfl\u00fcgersArchiv"},{"key":"477_CR68","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/01.ALC.0000056614.96137.B8","volume":"27","author":"C Gianoulakis","year":"2003","unstructured":"Gianoulakis C, Dai X, Brown T (2003) Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary \u03b2-endorphin as a function of alcohol intake, age, and gender. Alcohol Clin Exp Res 27:410\u2013423. https:\/\/doi.org\/10.1097\/01.ALC.0000056614.96137.B8","journal-title":"Alcohol Clin Exp Res"},{"key":"477_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-020-00329-0","volume":"11","author":"EY Gohar","year":"2020","unstructured":"Gohar EY, Kasztan M, Zhang S, Inscho EW, Pollock DM (2020) Role for ovarian hormones in purinoceptor-dependent natriuresis. Biol Sex Differ 11:1\u201310. https:\/\/doi.org\/10.1186\/s13293-020-00329-0","journal-title":"Biol Sex Differ"},{"key":"477_CR70","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.1073\/pnas.87.24.9717","volume":"87","author":"FA Gonzalez","year":"1990","unstructured":"Gonzalez FA, Wang DJ, Huang NN, Heppel LA (1990) Activation of early events of the mitogenic response by a P2Y purinoceptor with covalently bound 3\u2019-O-(4-benzoyl)-benzoyladenosine 5\u2019-triphosphate. Proc Natl Acad Sci 87:9717\u20139721. https:\/\/doi.org\/10.1073\/pnas.87.24.9717","journal-title":"Proc Natl Acad Sci"},{"key":"477_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/bj2330309","volume":"233","author":"JL Gordon","year":"1986","unstructured":"Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309\u2013319. https:\/\/doi.org\/10.1042\/bj2330309","journal-title":"Biochem J"},{"key":"477_CR72","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/BF00966695","volume":"16","author":"SC Guru","year":"1991","unstructured":"Guru SC, Shetty KT, Shankar SK (1991) Effect of chronic ethanol ingestion on phosphate content of neurofilament proteins and neurofilament associated protein phosphatase in rat spinal cord. Neurochem Res 16:1193\u20131197. https:\/\/doi.org\/10.1007\/BF00966695","journal-title":"Neurochem Res"},{"key":"477_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cld.2018.09.010","volume":"23","author":"N Hammoud","year":"2019","unstructured":"Hammoud N, Jimenez-Shahed J (2019) Chronic neurologic effects of alcohol. Clin Liver Dis 23:141\u2013155. https:\/\/doi.org\/10.1016\/j.cld.2018.09.010","journal-title":"Clin Liver Dis"},{"key":"477_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1254\/jphs.10264FP","volume":"115","author":"S Harada","year":"2011","unstructured":"Harada S, Fujita-Hamabe W, Tokuyama S (2011) RETRACTED: Effect of Orexin-A on Post-ischemic Glucose Intolerance and Neuronal Damage. J Pharmacol Sci 115:155\u2013163. https:\/\/doi.org\/10.1254\/jphs.10264FP","journal-title":"J Pharmacol Sci"},{"key":"477_CR75","doi-asserted-by":"publisher","unstructured":"Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami KI, Goto K, Yanagisawa M, Sakurai T (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345\u2013354.\u00a0https:\/\/doi.org\/10.1016\/S0896-6273(01)00293-8","DOI":"10.1016\/S0896-6273(01)00293-8"},{"key":"477_CR76","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0306-4522(01)00033-1","volume":"103","author":"GJ Hervieu","year":"2001","unstructured":"Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA (2001) Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103:777\u2013797. https:\/\/doi.org\/10.1016\/S0306-4522(01)00033-1","journal-title":"Neuroscience"},{"key":"477_CR77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbr.2011.09.015","volume":"226","author":"WJ He","year":"2012","unstructured":"He WJ, Cui J, Du L, Zhao YD, Burnstock G, Zhou HD, Ruan HZ (2012) Spinal P2X7 receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model. Behav Brain Res 226:163\u2013170. https:\/\/doi.org\/10.1016\/j.bbr.2011.09.015","journal-title":"Behav Brain Res"},{"key":"477_CR78","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.1801693115","volume":"115","author":"A Hirano","year":"2018","unstructured":"Hirano A, Hsu PK, Zhang L et al (2018) DEC2 modulates orexin expression and regulates sleep. Proc Natl Acad Sci U S A 115:3434\u20133439. https:\/\/doi.org\/10.1073\/pnas.1801693115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21087-6","volume":"12","author":"C Hong","year":"2021","unstructured":"Hong C, Byrne NJ, Zamlynny B et al (2021) Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nature Commun 12:1\u201311. https:\/\/doi.org\/10.1038\/s41467-021-21087-6","journal-title":"Nature Commun"},{"key":"477_CR80","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1124\/jpet.106.111559","volume":"319","author":"P Honore","year":"2006","unstructured":"Honore P, Donnelly-Roberts D, Namovic MT et al (2006) A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl) acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319:1376\u20131385. https:\/\/doi.org\/10.1124\/jpet.106.111559","journal-title":"J Pharmacol Exp Ther"},{"key":"477_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3959(02)00032-5","volume":"99","author":"P Honore","year":"2002","unstructured":"Honore P, Kage K, Mikusa J et al (2002a) Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain 99:11\u201319. https:\/\/doi.org\/10.1016\/S0304-3959(02)00032-5","journal-title":"Pain"},{"key":"477_CR82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3959(01)00434-1","volume":"96","author":"P Honore","year":"2002","unstructured":"Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, Jarvis MF (2002b) TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain 96:99\u2013105. https:\/\/doi.org\/10.1016\/S0304-3959(01)00434-1","journal-title":"Pain"},{"key":"477_CR83","doi-asserted-by":"publisher","first-page":"H699","DOI":"10.1152\/ajpheart.00560.2020","volume":"320","author":"S H\u00f8rlyck","year":"2021","unstructured":"H\u00f8rlyck S, Cai C, Helms HC, Lauritzen M, Brodin B (2021) ATP induces contraction of cultured brain capillary pericytes via activation of P2Y-type purinergic receptors. Am J Physiol Heart Circ Physiol 320:H699\u2013H712. https:\/\/doi.org\/10.1152\/ajpheart.00560.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"477_CR84","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.nbd.2014.06.011","volume":"70","author":"G Horv\u00e1th","year":"2014","unstructured":"Horv\u00e1th G, G\u00f6l\u00f6ncs\u00e9r F, Cs\u00f6lle C et al (2014) Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiol Dis 70:162\u2013178. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.011","journal-title":"Neurobiol Dis"},{"key":"477_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P et al (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:1\u201320. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"key":"477_CR86","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1523\/JNEUROSCI.22-07-02660.2002","volume":"22","author":"LJ Hudson","year":"2002","unstructured":"Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, Winter J (2002) Metabotropic glutamate receptor 5 upregulation in A-fibres after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 22:2660\u20132668. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-07-02660.2002","journal-title":"J Neurosci"},{"key":"477_CR87","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.287.5455.1056","volume":"287","author":"C Ikonomidou","year":"2000","unstructured":"Ikonomidou C, Bittigau P, Ishimaru MJ et al (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056\u20131060. https:\/\/doi.org\/10.1126\/science.287.5455.1056","journal-title":"Science"},{"key":"477_CR88","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1126\/science.283.5398.70","volume":"283","author":"C Ikonomidou","year":"1999","unstructured":"Ikonomidou C, Bosch F, Miksa M et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70\u201374. https:\/\/doi.org\/10.1126\/science.283.5398.70","journal-title":"Science"},{"key":"477_CR89","doi-asserted-by":"publisher","first-page":"779","DOI":"10.5692\/clinicalneurol.49.779","volume":"49","author":"K Inoue","year":"2009","unstructured":"Inoue K (2009) The mechanism and control of neuropathic pain. Rinsho Shinkeigaku 49:779\u2013782. https:\/\/doi.org\/10.5692\/clinicalneurol.49.779","journal-title":"Rinsho Shinkeigaku"},{"key":"477_CR90","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/glia.20871","volume":"57","author":"K Inoue","year":"2009","unstructured":"Inoue K, Tsuda M (2009) Microglia and neuropathic pain. Glia 57:1469\u20131479. https:\/\/doi.org\/10.1002\/glia.20871","journal-title":"Glia"},{"key":"477_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2013.00018","volume":"4","author":"A Inutsuka","year":"2013","unstructured":"Inutsuka A, Yamanaka A (2013) The physiological role of orexin\/hypocretin neurons in the regulation of sleep\/wakefulness and neuroendocrine functions. Front Endocrinol 4:1\u201310. https:\/\/doi.org\/10.3389\/fendo.2013.00018","journal-title":"Front Endocrinol"},{"key":"477_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106045","volume":"176","author":"A Iring","year":"2021","unstructured":"Iring A, T\u00f3th A, Baranyi M et al (2021) The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson\u2019s disease: signalling pathway and novel therapeutic targets. Pharmacol Res 176:106045. https:\/\/doi.org\/10.1016\/j.phrs.2021.106045","journal-title":"Pharmacol Res"},{"key":"477_CR93","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00210-007-0197-z","volume":"377","author":"K Ito","year":"2008","unstructured":"Ito K, Iwami A, Katsura H, Ikeda M (2008) Therapeutic effects of the putative P2X 3\/P2X 2\/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats. Naunyn Schmiedebergs Arch Pharmacol 377:483\u2013490. https:\/\/doi.org\/10.1007\/s00210-007-0197-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"477_CR94","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neuroscience.2005.07.015","volume":"136","author":"Y Izumi","year":"2005","unstructured":"Izumi Y, Kitabayashi R, Funatsu M, Izumi M, Yuede C, Hartman RE, Wozniak DF, Zorumski CF (2005) A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, N-methyl-D-aspartate receptor function and ethanol sensitivity. Neuroscience 136:269\u2013279. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.07.015","journal-title":"Neuroscience"},{"key":"477_CR95","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/9780470032244.ch6","volume":"276","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Costanzi S, Joshi BV, Besada P, Shin DH, Ko H, Ivanov AA, Mamedova L (2006) Agonists and antagonists for P2 receptors. Novartis Found Symp 276:58\u2013281. https:\/\/doi.org\/10.1002\/9780470032244.ch6","journal-title":"Novartis Found Symp"},{"key":"477_CR96","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/bph.15005","volume":"177","author":"KA Jacobson","year":"2020","unstructured":"Jacobson KA, Delicado EG, Gachet C et al (2020) Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol 177:2413\u20132433. https:\/\/doi.org\/10.1111\/bph.15005","journal-title":"Br J Pharmacol"},{"key":"477_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tins.2009.10.003","volume":"33","author":"MF Jarvis","year":"2010","unstructured":"Jarvis MF (2010) The neural\u2013glial purinergic receptor ensemble in chronic pain states. Trends Neurosci 33:48\u201357. https:\/\/doi.org\/10.1016\/j.tins.2009.10.003","journal-title":"Trends Neurosci"},{"key":"477_CR98","doi-asserted-by":"publisher","first-page":"17179","DOI":"10.1073\/pnas.252537299","volume":"99","author":"MF Jarvis","year":"2002","unstructured":"Jarvis MF, Burgard EC, McGaraughty S et al (2002) A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2\/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 99:17179\u201317184. https:\/\/doi.org\/10.1073\/pnas.252537299","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/sj.bjp.0703793","volume":"132","author":"MF Jarvis","year":"2001","unstructured":"Jarvis MF, Wismer CT, Schweitzer E, Yu H, Van Biesen T, Lynch KJ, Burgard EC, Kowaluk EA (2001) Modulation of BzATP and formalin induced nociception: Attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X3 allosteric modulator, cibacron blue. Br J Pharmacol 132:259\u2013269. https:\/\/doi.org\/10.1038\/sj.bjp.0703793","journal-title":"Br J Pharmacol"},{"key":"477_CR100","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/(SICI)1096-9861(19990809)410:4%3C627::AID-CNE9%3E3.0.CO;2-8","volume":"410","author":"H Jia","year":"1999","unstructured":"Jia H, Rustioni A, Valtschanoff JG (1999) Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 410:627\u2013642. https:\/\/doi.org\/10.1002\/(SICI)1096-9861(19990809)410:4%3C627::AID-CNE9%3E3.0.CO;2-8","journal-title":"J Comp Neurol"},{"key":"477_CR101","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1111\/j.1460-9568.2004.03750.x","volume":"20","author":"EK Joseph","year":"2004","unstructured":"Joseph EK, Levine JD (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 20:2896\u20132902. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03750.x","journal-title":"Eur J Neurosci"},{"key":"477_CR102","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/6344","volume":"2","author":"YH Jo","year":"1999","unstructured":"Jo YH, Schlichter R (1999) Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat Neurosci 2:241\u2013245. https:\/\/doi.org\/10.1038\/6344","journal-title":"Nat Neurosci"},{"key":"477_CR103","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s00415-018-9123-1","volume":"266","author":"T Julian","year":"2019","unstructured":"Julian T, Glascow N, Syeed R, Zis P (2019) Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol 266:2907\u20132919. https:\/\/doi.org\/10.1007\/s00415-018-9123-1","journal-title":"J Neurol"},{"key":"477_CR104","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/35093019","volume":"413","author":"D Julius","year":"2001","unstructured":"Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203\u2013210. https:\/\/doi.org\/10.1038\/35093019","journal-title":"Nature"},{"key":"477_CR105","doi-asserted-by":"publisher","unstructured":"Jung ME, Gatch MB, Simpkins JW (2005) Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms. Exp Biol Med (Maywood) 230:8\u201322.\u00a0https:\/\/doi.org\/10.1177\/2F153537020523000102","DOI":"10.1177\/2F153537020523000102"},{"key":"477_CR106","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.brainres.2011.03.045","volume":"1391","author":"B Jupp","year":"2011","unstructured":"Jupp B, Krivdic B, Krstew E, Lawrence AJ (2011) The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 1391:54\u201359. https:\/\/doi.org\/10.1016\/j.brainres.2011.03.045","journal-title":"Brain Res"},{"key":"477_CR107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2012.01.019","volume":"511","author":"AD Kandhare","year":"2012","unstructured":"Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL (2012) Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett 511:18\u201322. https:\/\/doi.org\/10.1016\/j.neulet.2012.01.019","journal-title":"Neurosci Lett"},{"key":"477_CR108","first-page":"219","volume":"289","author":"AJ Kastin","year":"1999","unstructured":"Kastin AJ, Akerstrom V (1999) Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289:219\u2013223","journal-title":"J Pharmacol Exp Ther"},{"key":"477_CR109","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2016.07.006","volume":"110","author":"HE Kastman","year":"2016","unstructured":"Kastman HE, Blasiak A, Walker L, Siwiec M, Krstew EV, Gundlach AL, Lawrence AJ (2016) Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats. Neuropharmacology 110:82\u201391. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.006","journal-title":"Neuropharmacology"},{"key":"477_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep45208","volume":"7","author":"G Kasuya","year":"2017","unstructured":"Kasuya G, Fujiwara Y, Tsukamoto H et al (2017) Structural insights into the nucleotide base specificity of P2X receptors. Sci Rep 7:1\u201310. https:\/\/doi.org\/10.1038\/srep45208","journal-title":"Sci Rep"},{"key":"477_CR111","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2017.03.012","volume":"805","author":"M Kaur","year":"2017","unstructured":"Kaur M, Singh A, Kumar B et al (2017) Protective effect of co-administration of curcumin and sildenafil in alcohol induced neuropathy in rats. Eur J Pharmacol 805:58\u201366. https:\/\/doi.org\/10.1016\/j.ejphar.2017.03.012","journal-title":"Eur J Pharmacol"},{"key":"477_CR112","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neures.2015.04.008","volume":"98","author":"A Kawaguchi","year":"2015","unstructured":"Kawaguchi A, Sato M, Kimura M, Ichinohe T, Tazaki M, Shibukawa Y (2015) Expression and function of purinergic P2Y12 receptors in rat trigeminal ganglion neurons. Neurosci Res 98:17\u201327. https:\/\/doi.org\/10.1016\/j.neures.2015.04.008","journal-title":"Neurosci Res"},{"key":"477_CR113","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461\u2013553. https:\/\/doi.org\/10.1152\/physrev.00011.2010","journal-title":"Physiol Rev"},{"key":"477_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pain.2005.03.040","volume":"116","author":"SG Khasar","year":"2005","unstructured":"Khasar SG, Green PG, Levine JD (2005) Repeated sound stress enhances inflammatory pain in the rat. Pain 116:79\u201386. https:\/\/doi.org\/10.1016\/j.pain.2005.03.040","journal-title":"Pain"},{"key":"477_CR115","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0896-6273(00)80837-5","volume":"24","author":"SG Khasar","year":"1999","unstructured":"Khasar SG, Lin YH, Martin A et al (1999) A novel nociceptor signaling pathway revealed in protein kinase C \u03b5 mutant mice. Neuron 24:253\u2013260. https:\/\/doi.org\/10.1016\/S0896-6273(00)80837-5","journal-title":"Neuron"},{"key":"477_CR116","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neures.2010.06.010","volume":"68","author":"E Kitamura","year":"2010","unstructured":"Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, Mochizuki H (2010) The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res 68:154\u2013157. https:\/\/doi.org\/10.1016\/j.neures.2010.06.010","journal-title":"Neurosci Res"},{"key":"477_CR117","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2011.08.058","volume":"504","author":"K Kobayashi","year":"2011","unstructured":"Kobayashi K, Takahashi E, Miyagawa Y, Yamanaka H, Noguchi K (2011) Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neurosci Lett 504:57\u201361. https:\/\/doi.org\/10.1016\/j.neulet.2011.08.058","journal-title":"Neurosci Lett"},{"key":"477_CR118","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1212\/WNL.56.12.1727","volume":"56","author":"H Koike","year":"2001","unstructured":"Koike H, Mori K, Misu K, Hattori N, Ito H, Hirayama M, Sobue G (2001) Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 56:1727\u20131732. https:\/\/doi.org\/10.1212\/WNL.56.12.1727","journal-title":"Neurology"},{"key":"477_CR119","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.wco.0000245371.89941.eb","volume":"19","author":"H Koike","year":"2006","unstructured":"Koike H, Sobue G (2006) Alcoholic Neuropathy Curropinneurol 19:481\u2013486. https:\/\/doi.org\/10.1097\/01.wco.0000245371.89941.eb","journal-title":"Alcoholic Neuropathy Curropinneurol"},{"key":"477_CR120","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.2174\/138161207781368747","volume":"13","author":"L Koles","year":"2007","unstructured":"Koles L, Furst S, Illes P (2007) Purine ionotropic (P2X) receptors. Curr Pharm Des 13:2368\u20132384. https:\/\/doi.org\/10.2174\/138161207781368747","journal-title":"Curr Pharm Des"},{"key":"477_CR121","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.144.5.915","volume":"144","author":"JF Krebs","year":"1999","unstructured":"Krebs JF, Armstrong RC, Srinivasan A et al (1999) Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J Cell Biol 144:915\u2013926. https:\/\/doi.org\/10.1083\/jcb.144.5.915","journal-title":"J Cell Biol"},{"key":"477_CR122","first-page":"26","volume":"103","author":"P Kucera","year":"2002","unstructured":"Kucera P, Balaz M, Varsik P, Kurca E (2002) Pathogenesis of alcoholic neuropathy. Bratisl Lek Listy 103:26\u201329","journal-title":"Bratisl Lek Listy"},{"key":"477_CR123","doi-asserted-by":"publisher","unstructured":"Kukkonen JP (2016) Orexin\/hypocretin signaling. In: Lawrence A, de Lecea L (eds) Behavioral Neuroscience of Orexin\/Hypocretin. Curr Top Behav Neurosci Springer Cham 33:17\u201350. https:\/\/doi.org\/10.1007\/7854_2016_49","DOI":"10.1007\/7854_2016_49"},{"key":"477_CR124","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bph.12324","volume":"171","author":"JP Kukkonen","year":"2014","unstructured":"Kukkonen JP, Leonard CS (2014) Orexin\/hypocretin receptor signalling cascades. Br J Pharmacol 171:314\u2013331. https:\/\/doi.org\/10.1111\/bph.12324","journal-title":"Br J Pharmacol"},{"key":"477_CR125","doi-asserted-by":"publisher","unstructured":"Kwon SG, Roh DH, Yoon SY et al (2014) Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain. Mol Pain 10:2. https:\/\/doi.org\/10.1186\/2F1744-8069-10-2","DOI":"10.1186\/2F1744-8069-10-2"},{"key":"477_CR126","doi-asserted-by":"publisher","unstructured":"La Herr\u00e1n-Arita D, Alberto K, Guerra-Crespo M, Drucker-Colin R (2011) Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2:1\u20138.\u00a0https:\/\/doi.org\/10.3389\/fneur.2011.00026","DOI":"10.3389\/fneur.2011.00026"},{"key":"477_CR127","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/brainsci11081098","volume":"11","author":"ME La Torre","year":"2021","unstructured":"La Torre ME, Villano I, Monda M et al (2021) Role of vitamin E and the orexin system in neuroprotection. Brain Sci 11:1098. https:\/\/doi.org\/10.3390\/brainsci11081098","journal-title":"Brain Sci"},{"key":"477_CR128","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainres.2009.07.072","volume":"1314","author":"AJ Lawrence","year":"2010","unstructured":"Lawrence AJ (2010) Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 1314:124\u2013129. https:\/\/doi.org\/10.1016\/j.brainres.2009.07.072","journal-title":"Brain Res"},{"key":"477_CR129","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","volume":"148","author":"AJ Lawrence","year":"2006","unstructured":"Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006) The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148:752\u2013759. https:\/\/doi.org\/10.1038\/sj.bjp.0706789","journal-title":"Br J Pharmacol"},{"key":"477_CR130","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/fcp.12433","volume":"33","author":"B Le Dar\u00e9","year":"2019","unstructured":"Le Dar\u00e9 B, Victoni T, Bodin A et al (2019) Ethanol upregulates the P2X7 purinergic receptor in human macrophages. Fundam Clin Pharmacol 33:63\u201374. https:\/\/doi.org\/10.1111\/fcp.12433","journal-title":"Fundam Clin Pharmacol"},{"key":"477_CR131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2007.01.035","volume":"133","author":"I Lee","year":"2007","unstructured":"Lee I, Kim HK, Kim JH, Chung K, Chung JM (2007) The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 133:9\u201317. https:\/\/doi.org\/10.1016\/j.pain.2007.01.035","journal-title":"Pain"},{"key":"477_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1533-2500.2004.04002.x","volume":"4","author":"D Levy","year":"2004","unstructured":"Levy D, Zochodne DW (2004) NO pain: potential roles of nitric oxide in neuropathic pain. Pain Pract 4:11\u201318. https:\/\/doi.org\/10.1111\/j.1533-2500.2004.04002.x","journal-title":"Pain Pract"},{"key":"477_CR133","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.brainres.2003.09.070","volume":"995","author":"SD Liang","year":"2004","unstructured":"Liang SD, Gao Y, Xu CS, Xu BH, Mu SN (2004) Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res 995:247\u2013252. https:\/\/doi.org\/10.1016\/j.brainres.2003.09.070","journal-title":"Brain Res"},{"key":"477_CR134","doi-asserted-by":"publisher","unstructured":"Lieber CS (1998) Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. J Stud Alcohol 59:9\u201325. https:\/\/doi.org\/10.15288\/jsa.1998.59.9","DOI":"10.15288\/jsa.1998.59.9"},{"key":"477_CR135","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S1740925X05000323","volume":"2","author":"AR Light","year":"2006","unstructured":"Light AR, Wu Y, Hughen RW, Guthrie PB (2006) Purinergic receptors activating rapid intracellular Ca2+ increases in microglia. Neuron Glia Biol 2:125\u2013138. https:\/\/doi.org\/10.1017\/S1740925X05000323","journal-title":"Neuron Glia Biol"},{"key":"477_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01841-1","volume":"17","author":"T Li","year":"2020","unstructured":"Li T, Xu W, Ouyang J, Lu X, Sherchan P, Lenahan C, Irio G, Zhang JH, Zhao J, Zhang Y, Tang J (2020) Orexin A alleviates neuroinflammation via OXR2\/CaMKK\u03b2\/AMPK signaling pathway after ICH in mice. J Neuroinflammation 17:1\u201315. https:\/\/doi.org\/10.1186\/s12974-020-01841-1","journal-title":"J Neuroinflammation"},{"key":"477_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-019-1070-4","volume":"21","author":"T Long","year":"2020","unstructured":"Long T, He W, Pan Q, Zhang S, Zhang D, Qin G, Chen L, Zhou J (2020) Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model. J Headache Pain 21:1\u20137. https:\/\/doi.org\/10.1186\/s10194-019-1070-4","journal-title":"J Headache Pain"},{"key":"477_CR138","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2016.01.049","volume":"1636","author":"MF Lopez","year":"2016","unstructured":"Lopez MF, Moorman DE, Aston-Jones G, Becker HC (2016) The highly selective orexin\/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res 1636:74\u201380. https:\/\/doi.org\/10.1016\/j.brainres.2016.01.049","journal-title":"Brain Res"},{"key":"477_CR139","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/B978-0-444-62619-6.00029-X","volume":"125","author":"RP Maiya","year":"2014","unstructured":"Maiya RP, Messing RO (2014) Peripheral systems: neuropathy. Handb Clin Neurol 125:513\u2013525. https:\/\/doi.org\/10.1016\/B978-0-444-62619-6.00029-X","journal-title":"Handb Clin Neurol"},{"key":"477_CR140","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/wmts.47","volume":"1","author":"T Makoto","year":"2012","unstructured":"Makoto T, Hidetoshi TS, Kazuhide I (2012) P2X4R and P2X7R in neuropathic pain. Wiley Interdiscip Rev Membr Transp Signal 1:513\u2013521. https:\/\/doi.org\/10.1002\/wmts.47","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"477_CR141","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0741-8329(01)00207-5","volume":"26","author":"Z Malatov\u00e1","year":"2002","unstructured":"Malatov\u00e1 Z, \u010c\u0131\u0301\u017ekov\u00e1 D (2002) Effect of ethanol on axonal transport of cholinergic enzymes in rat sciatic nerve. Alcohol 26:115\u2013120. https:\/\/doi.org\/10.1016\/S0741-8329(01)00207-5","journal-title":"Alcohol"},{"key":"477_CR142","doi-asserted-by":"publisher","unstructured":"Malin SA, Molliver DC (2010) Gi-and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol Pain 6:21. https:\/\/doi.org\/10.1186\/2F1744-8069-6-21","DOI":"10.1186\/2F1744-8069-6-21"},{"key":"477_CR143","first-page":"737","volume":"298","author":"A Mansouri","year":"2001","unstructured":"Mansouri A, Demeilliers C, Amsellem S, Pessayre D, Fromenty B (2001) Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther 298:737\u2013743","journal-title":"J Pharmacol Exp Ther"},{"key":"477_CR144","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cne.1190","volume":"435","author":"JN Marcus","year":"2001","unstructured":"Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6\u201325. https:\/\/doi.org\/10.1002\/cne.1190","journal-title":"J Comp Neurol"},{"key":"477_CR145","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neulet.2004.04.009","volume":"363","author":"T Masaki","year":"2004","unstructured":"Masaki T, Mochizuki H, Matsushita S, Yokoyama A, Kamakura K, Higuchi S (2004) Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans. Neurosci Lett 363:288\u2013290. https:\/\/doi.org\/10.1016\/j.neulet.2004.04.009","journal-title":"Neurosci Lett"},{"key":"477_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32461","volume":"6","author":"Y Matsumura","year":"2016","unstructured":"Matsumura Y, Yamashita T, Sasaki A et al (2016) A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain. Sci Rep 6:1\u201311. https:\/\/doi.org\/10.1038\/srep32461","journal-title":"Sci Rep"},{"key":"477_CR147","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ddr.20101","volume":"67","author":"S McGaraughty","year":"2006","unstructured":"McGaraughty S, Jarvis MF (2006) Purinergic control of neuropathic pain. Drug Dev Res 67:376\u2013388. https:\/\/doi.org\/10.1002\/ddr.20101","journal-title":"Drug Dev Res"},{"key":"477_CR148","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/sj.bjp.0705574","volume":"140","author":"S McGaraughty","year":"2003","unstructured":"McGaraughty S, Wismer CT, Zhu CZ et al (2003) Effects of A-317491, a novel and selective P2X3\/P2X2\/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 140:1381\u20131388. https:\/\/doi.org\/10.1038\/sj.bjp.0705574","journal-title":"Br J Pharmacol"},{"key":"477_CR149","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0741-8329(87)90071-1","volume":"4","author":"JA McLane","year":"1987","unstructured":"McLane JA (1987) Decreased axonal transport in rat nerve following acute and chronic ethanol exposure. Alcohol 4:385\u2013389. https:\/\/doi.org\/10.1016\/0741-8329(87)90071-1","journal-title":"Alcohol"},{"key":"477_CR150","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1016\/j.bbadis.2018.08.023","volume":"1864","author":"N Messal","year":"2018","unstructured":"Messal N, Fernandez N, Dayot S, Gratio V, Nicole P, Prochasson C, Chantret I, LeGuilloux G, Jarry A, Couvelard A, Tr\u00e9ton X et al (2018) Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A. BiochimBiophys Acta Mol Basis Dis 1864:3618\u20133628. https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.023","journal-title":"BiochimBiophys Acta Mol Basis Dis"},{"key":"477_CR151","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2006.08.083","volume":"410","author":"K Miyoshi","year":"2006","unstructured":"Miyoshi K, Narita M, Narita M, Suzuki T (2006) Involvement of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett 410:105\u2013109. https:\/\/doi.org\/10.1016\/j.neulet.2006.08.083","journal-title":"Neurosci Lett"},{"key":"477_CR152","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejphar.2007.01.091","volume":"562","author":"K Miyoshi","year":"2007","unstructured":"Miyoshi K, Narita M, Takatsu M, Suzuki T (2007) mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. Eur J Pharmacol 562:208\u2013211. https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.091","journal-title":"Eur J Pharmacol"},{"key":"477_CR153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archneur.1995.00540250049012","volume":"52","author":"R Monforte","year":"1995","unstructured":"Monforte R, Estruch R, Valls-Sol\u00e9 J, Nicol\u00e1s J, Villalta J, Urbano-Marquez A (1995) Autonomic and peripheral neuropathies in patients with chronic alcoholism: a dose-related toxic effect of alcohol. Arch Neurol 52:45\u201351. https:\/\/doi.org\/10.1001\/archneur.1995.00540250049012","journal-title":"Arch Neurol"},{"key":"477_CR154","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pain.2004.07.016","volume":"111","author":"K Morita","year":"2004","unstructured":"Morita K, Morioka N, Abdin J, Kitayama S, Nakata Y, Dohi T (2004) Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111:351\u2013359. https:\/\/doi.org\/10.1016\/j.pain.2004.07.016","journal-title":"Pain"},{"key":"477_CR155","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/bjp.2008.3","volume":"154","author":"SG Nair","year":"2008","unstructured":"Nair SG, Golden SA, Shaham Y (2008) Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol 154:406\u2013416. https:\/\/doi.org\/10.1038\/bjp.2008.3","journal-title":"Br J Pharmacol"},{"key":"477_CR156","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2006.10.062","volume":"414","author":"M Narita","year":"2007","unstructured":"Narita M, Miyoshi K, Narita M, Suzuki T (2007) Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett 414:21\u201325. https:\/\/doi.org\/10.1016\/j.neulet.2006.10.062","journal-title":"Neurosci Lett"},{"key":"477_CR157","first-page":"224","volume":"50","author":"RA Nicholas","year":"1996","unstructured":"Nicholas RA, Watt WC, Lazarowski ER, Li Q, Harden K (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-specific receptor. Mol Pharmacol 50:224\u2013229","journal-title":"Mol Pharmacol"},{"key":"477_CR158","doi-asserted-by":"publisher","unstructured":"Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295\u2013322. https:\/\/doi.org\/10.1146\/annurev.pharmtox.011008.145533","DOI":"10.1146\/annurev.pharmtox.011008.145533"},{"key":"477_CR159","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1212\/01.CON.0000450970.99322.84","volume":"20","author":"JM Noble","year":"2014","unstructured":"Noble JM, Weimer LH (2014) Neurologic Complications of Alcoholism Continuum (MinneapMinn) 20:624\u2013641. https:\/\/doi.org\/10.1212\/01.CON.0000450970.99322.84","journal-title":"Neurologic Complications of Alcoholism Continuum (MinneapMinn)"},{"key":"477_CR160","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1113\/jphysiol.2003.048587","volume":"554","author":"RA North","year":"2004","unstructured":"North RA (2004) P2X3 receptors and peripheral pain mechanisms. J Physiol 554:301\u2013308. https:\/\/doi.org\/10.1113\/jphysiol.2003.048587","journal-title":"J Physiol"},{"key":"477_CR161","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1124\/mol.112.083758","volume":"83","author":"RA North","year":"2013","unstructured":"North RA, Jarvis MF (2013) P2X receptors as drug targets. Mol Pharmacol 83:759\u2013769","journal-title":"Mol Pharmacol"},{"key":"477_CR162","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-10-53","volume":"10","author":"R Ochi-Ishi","year":"2014","unstructured":"Ochi-Ishi R, Nagata K, Inoue T, Tozaki-Saitoh H, Tsuda M, Inoue K (2014) Involvement of the chemokine CCL3 and the purinoceptor p2\u00d7 7 in the spinal cord in paclitaxel-induced mechanical allodynia. Mol Pain 10:1744\u20138069. https:\/\/doi.org\/10.1186\/1744-8069-10-53","journal-title":"Mol Pain"},{"key":"477_CR163","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0165-6147(91)90530-6","volume":"12","author":"SE O'Connor","year":"1991","unstructured":"O\u2019Connor SE, Dainty IA, Leff P (1991) Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 12:137\u2013141. https:\/\/doi.org\/10.1016\/0165-6147(91)90530-6","journal-title":"Trends Pharmacol Sci"},{"key":"477_CR164","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1124\/jpet.102.036079","volume":"303","author":"M Okada","year":"2002","unstructured":"Okada M, Nakagawa T, Minami M, Satoh M (2002) Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303:66\u201373. https:\/\/doi.org\/10.1124\/jpet.102.036079","journal-title":"J Pharmacol Exp Ther"},{"key":"477_CR165","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-012-9329-0","volume":"9","author":"P Ohlmann","year":"2013","unstructured":"Ohlmann P, Lecchi A, El-Tayeb A, M\u00fcller CE, Cattaneo M, Gachet C (2013) The platelet P2Y 12 receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [3 H] PSB-0413. Purinergic Signal 9:59\u201366. https:\/\/doi.org\/10.1007\/s11302-012-9329-0","journal-title":"Purinergic Signal"},{"key":"477_CR166","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pain.2008.10.024","volume":"141","author":"MC Oliveira","year":"2009","unstructured":"Oliveira MC, Pelegrini-da-Silva A, Tambeli CH, Parada CA (2009) Peripheral mechanisms underlying the essential role of P2X3, 2\/3 receptors in the development of inflammatory hyperalgesia. Pain 141:127\u2013134. https:\/\/doi.org\/10.1016\/j.pain.2008.10.024","journal-title":"Pain"},{"key":"477_CR167","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna NA, Donohue TM Jr, Kharbanda KK (2017) Alcoholic liver disease: pathogenesis and current management. Alcohol Res 38:147\u2013161","journal-title":"Alcohol Res"},{"key":"477_CR168","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3390\/ijms21072471","volume":"21","author":"M Popova","year":"2020","unstructured":"Popova M, Rodriguez L, Trudell JR, Nguyen S, Bloomfield M, Davies DL, Asatryan L (2020) Residues in transmembrane segments of the P2X4 receptor contribute to channel function and ethanol sensitivity. Int J Mol Sci 21:2471. https:\/\/doi.org\/10.3390\/ijms21072471","journal-title":"Int J Mol Sci"},{"key":"477_CR169","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0960-894X(01)00343-2","volume":"11","author":"RA Porter","year":"2001","unstructured":"Porter RA, Chan WN, Coulton S, Johns A, Hadley MS, Widdowson K, Jerman JC, Brough SJ, Coldwell M, Smart D, Jewitt F, Jeffrey P, Austin N (2001) 1, 3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorg Med Chem Lett 11:1907\u20131910. https:\/\/doi.org\/10.1016\/S0960-894X(01)00343-2","journal-title":"Bioorg Med Chem Lett"},{"key":"477_CR170","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0968-0896(98)00038-8","volume":"6","author":"SA Poulsen","year":"1998","unstructured":"Poulsen SA, Quinn RJ (1998) Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6:619\u2013641. https:\/\/doi.org\/10.1016\/S0968-0896(98)00038-8","journal-title":"Bioorg Med Chem"},{"key":"477_CR171","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1111\/bph.12883","volume":"171","author":"J Putula","year":"2014","unstructured":"Putula J, Pihlajamaa T, Kukkonen JP (2014) Calcium affects OX 1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery. Br J Pharmacol 171:5816\u20135828. https:\/\/doi.org\/10.1111\/bph.12883","journal-title":"Br J Pharmacol"},{"key":"477_CR172","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0006-8993(02)04224-5","volume":"965","author":"L Quintero","year":"2003","unstructured":"Quintero L, Cuesta MC, Silva JA, Arcaya JL, Pinerua-Suhaibar L, Maixner W, Suarez-Roca H (2003) Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord. Brain Res 965:259\u2013268. https:\/\/doi.org\/10.1016\/S0006-8993(02)04224-5","journal-title":"Brain Res"},{"key":"477_CR173","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1124\/jpet.103.052407","volume":"306","author":"V Raghavendra","year":"2003","unstructured":"Raghavendra V, Tanga F, DeLeo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624\u2013630. https:\/\/doi.org\/10.1124\/jpet.103.052407","journal-title":"J Pharmacol Exp Ther"},{"key":"477_CR174","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10787-012-0122-z","volume":"20","author":"KS Raygude","year":"2012","unstructured":"Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL (2012) Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology 20:331\u2013341. https:\/\/doi.org\/10.1007\/s10787-012-0122-z","journal-title":"Inflammopharmacology"},{"key":"477_CR175","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1210\/en.2003-0266","volume":"144","author":"MA Robbins","year":"2003","unstructured":"Robbins MA, Maksumova L, Pocock E, Chantler JK (2003) Nuclear factor-\u03baB translocation mediates double-stranded ribonucleic acid-induced NIT-1 \u03b2-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL). Endocrinology 144:4616\u20134625. https:\/\/doi.org\/10.1210\/en.2003-0266","journal-title":"Endocrinology"},{"key":"477_CR176","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0014-2999(01)00761-0","volume":"413","author":"AJ Robinson","year":"2001","unstructured":"Robinson AJ, Dickenson JM (2001) Regulation of p42\/p44 MAPK and p38 MAPK by the adenosine A1 receptor in DDT1MF-2 cells. Eur J Pharmacol 413:151\u2013161. https:\/\/doi.org\/10.1016\/S0014-2999(01)00761-0","journal-title":"Eur J Pharmacol"},{"key":"477_CR177","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","volume":"13","author":"RJ Rodgers","year":"2001","unstructured":"Rodgers RJ, Halford JC, Nunes de Souza RL et al (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13:1444\u20131452. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01518.x","journal-title":"Eur J Neurosci"},{"key":"477_CR178","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsps.2012.05.011","volume":"21","author":"S Sachdeva","year":"2013","unstructured":"Sachdeva S, Gupta M (2013) Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm J 21:245\u2013253. https:\/\/doi.org\/10.1016\/j.jsps.2012.05.011","journal-title":"Saudi Pharm J"},{"key":"477_CR179","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR et al (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573\u2013585. https:\/\/doi.org\/10.1016\/S0092-8674(00)80949-6","journal-title":"Cell"},{"key":"477_CR180","doi-asserted-by":"publisher","first-page":"17771","DOI":"10.1074\/jbc.274.25.17771","volume":"274","author":"T Sakurai","year":"1999","unstructured":"Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, Goto K (1999) Structure and function of human prepro-orexin gene. J Biol Chem 274:17771\u201317776. https:\/\/doi.org\/10.1074\/jbc.274.25.17771","journal-title":"J Biol Chem"},{"key":"477_CR181","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0741-8329(97)00043-8","volume":"14","author":"DE Saunders","year":"1997","unstructured":"Saunders DE, DiCerbo JA, Williams JR, Hannigan JH (1997) Alcohol reduces neurofilament pritein levels in primary cultured hippocampal neurons. Alcohol 14:519\u2013526. https:\/\/doi.org\/10.1016\/S0741-8329(97)00043-8","journal-title":"Alcohol"},{"key":"477_CR182","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-physiol-020518-114259","volume":"81","author":"R Schmid","year":"2019","unstructured":"Schmid R, Evans RJ (2019) ATP-gated P2X receptor channels: molecular insights into functional roles. Annu Rev Physiol 81:43\u201362. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114259","journal-title":"Annu Rev Physiol"},{"key":"477_CR183","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","volume":"10","author":"J Scholz","year":"2007","unstructured":"Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361\u20131368. https:\/\/doi.org\/10.1038\/nn1992","journal-title":"Nat Neurosci"},{"key":"477_CR184","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0165-6147(89)90009-6","volume":"10","author":"R Seifert","year":"1989","unstructured":"Seifert R, Schultz G (1989) Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol Sci 10:365\u2013369. https:\/\/doi.org\/10.1016\/0165-6147(89)90009-6","journal-title":"Trends Pharmacol Sci"},{"key":"477_CR185","doi-asserted-by":"publisher","unstructured":"Sharma SS, Sayyed SG (2006) Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Clin Exp Pharmacol Physiol 33:1022\u20131028. https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04481.x","DOI":"10.1111\/j.1440-1681.2006.04481.x"},{"key":"477_CR186","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1875-5364(20)30002-9","volume":"18","author":"LI Shun-Hua","year":"2020","unstructured":"Shun-Hua LI, Lin LI, Ru-Nan YA, Liang SD (2020) Compounds of traditional Chinese medicine and neuropathic pain. Chin J Nat Med 18:28\u201335. https:\/\/doi.org\/10.1016\/S1875-5364(20)30002-9","journal-title":"Chin J Nat Med"},{"key":"477_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-018-0879-6","volume":"20","author":"M Sieminski","year":"2018","unstructured":"Sieminski M, Szypenbejl J, Partinen E (2018) Orexins, sleep, and blood pressure. CurrHypertens Rep 20:1\u20138. https:\/\/doi.org\/10.1007\/s11906-018-0879-6","journal-title":"CurrHypertens Rep"},{"key":"477_CR188","doi-asserted-by":"publisher","first-page":"31390","DOI":"10.1074\/jbc.M110714200","volume":"277","author":"J Simon","year":"2002","unstructured":"Simon J, Filippov AK, G\u00f6ransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA (2002) Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial Cells. J Biol Chem 277:31390\u201331400. https:\/\/doi.org\/10.1074\/jbc.M110714200","journal-title":"J Biol Chem"},{"key":"477_CR189","doi-asserted-by":"publisher","unstructured":"Singh B, Moodley J, Shaik AS, Robbs JV (2003) Sympathectomy for complex regional pain syndrome. J Vasc Surg 37:508\u2013511. https:\/\/doi.org\/10.1067\/mva.2003.78","DOI":"10.1067\/mva.2003.78"},{"key":"477_CR190","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1566524013363870","volume":"1","author":"CK Singleton","year":"2001","unstructured":"Singleton CK, Martin PR (2001) Molecular mechanisms of thiamine utilization. Curr Mol Med 1:197\u2013207. https:\/\/doi.org\/10.2174\/1566524013363870","journal-title":"Curr Mol Med"},{"key":"477_CR191","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1096\/fj.09-138883","volume":"24","author":"SD Skaper","year":"2010","unstructured":"Skaper SD, Debetto P, Giusti P (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24:337\u2013345. https:\/\/doi.org\/10.1096\/fj.09-138883","journal-title":"FASEB J"},{"key":"477_CR192","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.3390\/ijms21228572","volume":"21","author":"RA Sophocleous","year":"2020","unstructured":"Sophocleous RA, Miles NA, Ooi L, Sluyter R (2020) P2Y2 and P2X4 Receptors Mediate Ca2+ Mobilization in DH82 Canine Macrophage Cells. Int J Mol Sci 21:8572. https:\/\/doi.org\/10.3390\/ijms21228572","journal-title":"Int J Mol Sci"},{"key":"477_CR193","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","volume":"149","author":"L Stokes","year":"2006","unstructured":"Stokes L, Jiang LH, Alcaraz L et al (2006) Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373. Br J Pharmacol 149:880\u2013887. https:\/\/doi.org\/10.1038\/sj.bjp.0706933","journal-title":"Br J Pharmacol"},{"key":"477_CR194","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.biopha.2018.07.159","volume":"107","author":"M Sun","year":"2018","unstructured":"Sun M, Wang W, Li Q, Yuan T, Weng W (2018) Orexin A may suppress inflammatory response in fibroblast-like synoviocytes. Biomed Pharmacother 107:763\u2013768. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.159","journal-title":"Biomed Pharmacother"},{"key":"477_CR195","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-013-1233-3","volume":"127","author":"M Suzanne","year":"2014","unstructured":"Suzanne M, Kril JJ (2014) Human alcohol-related neuropathology. Acta Neuropathol 127:71\u201390. https:\/\/doi.org\/10.1007\/s00401-013-1233-3","journal-title":"Acta Neuropathol"},{"key":"477_CR196","doi-asserted-by":"publisher","first-page":"220S","DOI":"10.1097\/01.alc.0000190657.97988.c7","volume":"29","author":"M Takeuchi","year":"2005","unstructured":"Takeuchi M, Saito T (2005) Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration. Alcohol Clin Exp Res 29:220S-224S. https:\/\/doi.org\/10.1097\/01.alc.0000190657.97988.c7","journal-title":"Alcohol Clin Exp Res"},{"key":"477_CR197","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpsycho.2005.10.013","volume":"59","author":"JF Thayer","year":"2006","unstructured":"Thayer JF, Hall M, Sollers JJ III, Fischer JE (2006) Alcohol use, urinary cortisol, and heart rate variability in apparently healthy men: Evidence for impaired inhibitory control of the HPA axis in heavy drinkers. Int J Psychophysiol 59:244\u2013250. https:\/\/doi.org\/10.1016\/j.ijpsycho.2005.10.013","journal-title":"Int J Psychophysiol"},{"key":"477_CR198","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejpain.2010.07.005","volume":"15","author":"V Tiwari","year":"2011","unstructured":"Tiwari V, Kuhad A, Chopra K (2011) Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy. Eur J Pain 15:286\u2013292. https:\/\/doi.org\/10.1016\/j.ejpain.2010.07.005","journal-title":"Eur J Pain"},{"key":"477_CR199","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/ptr.4635","volume":"26","author":"V Tiwari","year":"2012","unstructured":"Tiwari V, Kuhad A, Chopra K (2012) Neuroprotective Effect of Vitamin E Isoforms Against Chronic Alcohol-induced Peripheral Neurotoxicity: Possible Involvement of Oxidative-Nitrodative Stress. Phytother Res 26:1738\u20131745. https:\/\/doi.org\/10.1002\/ptr.4635","journal-title":"Phytother Res"},{"key":"477_CR200","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.2042-7158.1996.tb07124.x","volume":"48","author":"NP Tomkinson","year":"1996","unstructured":"Tomkinson NP, Marriott DP, Cage PA et al (1996) P2T Purinoceptor Antagonists. A QSAR Study of Some 2-Substituted ATP Analogues. J Pharm Pharmacol 48:206\u2013209. https:\/\/doi.org\/10.1111\/j.2042-7158.1996.tb07124.x","journal-title":"J Pharm Pharmacol"},{"key":"477_CR201","doi-asserted-by":"publisher","unstructured":"Toyoda H, Zhao MG, Zhuo M (2009) Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain. Mol Pain 5:4. https:\/\/doi.org\/10.1186\/2F1744-8069-5-4","DOI":"10.1186\/2F1744-8069-5-4"},{"key":"477_CR202","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1523\/JNEUROSCI.0323-08.2008","volume":"28","author":"H Tozaki-Saitoh","year":"2008","unstructured":"Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K (2008) P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 28:4949\u20134956. https:\/\/doi.org\/10.1523\/JNEUROSCI.0323-08.2008","journal-title":"J Neurosci"},{"key":"477_CR203","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0304-3959(94)00141-Z","volume":"60","author":"DJ Tracey","year":"1995","unstructured":"Tracey DJ, Cunningham JE, Romm MA (1995) Peripheral hyperalgesia in experimental neuropathy: mediation by \u03b12-adrenoreceptors on post-ganglionic sympathetic terminals. Pain 60:317\u2013327. https:\/\/doi.org\/10.1016\/0304-3959(94)00141-Z","journal-title":"Pain"},{"key":"477_CR204","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S1740925X12000087","volume":"7","author":"T Trang","year":"2011","unstructured":"Trang T, Beggs S, Salter MW (2011) Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 7:99\u2013108. https:\/\/doi.org\/10.1017\/S1740925X12000087","journal-title":"Neuron Glia Biol"},{"key":"477_CR205","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1471-4159.2007.04861.x","volume":"103","author":"M Tsuda","year":"2007","unstructured":"Tsuda M, Hasegawa S, Inoue K (2007) P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J Neurochem 103:1408\u20131416. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04861.x","journal-title":"J Neurochem"},{"key":"477_CR206","doi-asserted-by":"publisher","unstructured":"Tsuda M, Kuboyama K, Inoue T, Nagata K, Tozaki-Saitoh H, Inoue K (2009) Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain 5:28. https:\/\/doi.org\/10.1186\/2F1744-8069-5-28","DOI":"10.1186\/2F1744-8069-5-28"},{"key":"477_CR207","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1073\/pnas.0810420106","volume":"106","author":"M Tsuda","year":"2009","unstructured":"Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K (2009b) IFN-\u03b3 receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci U S A 106:8032\u20138037. https:\/\/doi.org\/10.1073\/pnas.0810420106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR208","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/jnc.14001","volume":"141","author":"M Tsuda","year":"2017","unstructured":"Tsuda M, Koga K, Chen T, Zhuo M (2017) Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J Neurochem 141:486\u2013498. https:\/\/doi.org\/10.1111\/jnc.14001","journal-title":"J Neurochem"},{"key":"477_CR209","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nature01786","volume":"424","author":"M Tsuda","year":"2003","unstructured":"Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, InoueK, (2003) P2X 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778\u2013783. https:\/\/doi.org\/10.1038\/nature01786","journal-title":"Nature"},{"key":"477_CR210","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ddr.10208","volume":"59","author":"S Ueno","year":"2003","unstructured":"Ueno S, Moriyama T, Honda K, Kamiya HO, Sakurada T, Katsuragi T (2003) Involvement of P2X2 and P2X3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev Res 59:104\u2013111. https:\/\/doi.org\/10.1002\/ddr.10208","journal-title":"Drug Dev Res"},{"key":"477_CR211","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1523\/JNEUROSCI.2308-08.2008","volume":"28","author":"L Ulmann","year":"2008","unstructured":"Ulmann L, Hatcher JP, Hughes JP et al (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263\u201311268. https:\/\/doi.org\/10.1523\/JNEUROSCI.2308-08.2008","journal-title":"J Neurosci"},{"key":"477_CR212","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/mus.20168","volume":"30","author":"A Urbano-M\u00e1rquez","year":"2004","unstructured":"Urbano-M\u00e1rquez A, Fern\u00e1ndez-Sol\u00e0 J (2004) Effects of alcohol on skeletal and cardiac muscle. Muscle Nerve 30:689\u2013707. https:\/\/doi.org\/10.1002\/mus.20168","journal-title":"Muscle Nerve"},{"key":"477_CR213","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1097\/00001756-199708180-00012","volume":"8","author":"A Valerio","year":"1997","unstructured":"Valerio A, Paterlini M, Boifava M, Memo M, Spano P (1997) Metabotropic glutamate receptor mRNA expression in rat spinal cord. NeuroReport 8:2695\u20132699","journal-title":"NeuroReport"},{"key":"477_CR214","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/bies.201400024","volume":"36","author":"A Verkhratsky","year":"2014","unstructured":"Verkhratsky A, Burnstock G (2014) Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance. BioEssays 36:697\u2013705. https:\/\/doi.org\/10.1002\/bies.201400024","journal-title":"BioEssays"},{"key":"477_CR215","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/B978-0-12-385526-8.00012-6","volume":"61","author":"I von K\u00fcgelgen","year":"2011","unstructured":"von K\u00fcgelgen I, Harden TK (2011) Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol 61:373\u2013415. https:\/\/doi.org\/10.1016\/B978-0-12-385526-8.00012-6","journal-title":"Adv Pharmacol"},{"key":"477_CR216","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ygcen.2012.12.011","volume":"183","author":"A Wall","year":"2013","unstructured":"Wall A, Volkoff H (2013) Effects of fasting and feeding on the brain mRNA expressions of orexin, tyrosine hydroxylase (TH), PYY and CCK in the Mexican blind cavefish (Astyanax fasciatus mexicanus). Gen Comp Endocrinol 183:44\u201352. https:\/\/doi.org\/10.1016\/j.ygcen.2012.12.011","journal-title":"Gen Comp Endocrinol"},{"key":"477_CR217","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1369-1600.2006.00018.x","volume":"11","author":"M Walter","year":"2006","unstructured":"Walter M, Gerhard U, Gerlach M, Weijers HG, Boening J, Wiesbeck GA (2006) CLINICAL STUDY: Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence. Addict Biol 11:157\u2013162. https:\/\/doi.org\/10.1111\/j.1369-1600.2006.00018.x","journal-title":"Addict Biol"},{"key":"477_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2018.00220","volume":"11","author":"C Wang","year":"2018","unstructured":"Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J (2018) The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases. Front Mol Neurosci 11:1\u201316. https:\/\/doi.org\/10.3389\/fnmol.2018.00220","journal-title":"Front Mol Neurosci"},{"key":"477_CR219","doi-asserted-by":"publisher","first-page":"8595","DOI":"10.1523\/JNEUROSCI.3058-04.2004","volume":"24","author":"S Wang","year":"2004","unstructured":"Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J (2004) Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 24:8595\u20138605. https:\/\/doi.org\/10.1523\/JNEUROSCI.3058-04.2004","journal-title":"J Neurosci"},{"key":"477_CR220","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/jnr.23451","volume":"92","author":"WS Wang","year":"2014","unstructured":"Wang WS, Tu WZ, Cheng RD et al (2014) Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states. J Neurosci Res 92:1703\u20131713. https:\/\/doi.org\/10.1002\/jnr.23451","journal-title":"J Neurosci Res"},{"key":"477_CR221","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3959(01)00359-1","volume":"93","author":"LR Watkins","year":"2001","unstructured":"Watkins LR, Milligan ED, Maier SF (2001) Spinal cord glia: new players in pain. Pain 93:201\u2013205. https:\/\/doi.org\/10.1016\/S0304-3959(01)00359-1","journal-title":"Pain"},{"key":"477_CR222","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2004.09.056","volume":"504","author":"G Wu","year":"2004","unstructured":"Wu G, Whiteside GT, Lee G, Nolan S, Niosi M, Pearson MS, Ilyin VI (2004) A-317491, a selective P2X3\/P2X2\/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. Eur J Pharmacol 504:45\u201353. https:\/\/doi.org\/10.1016\/j.ejphar.2004.09.056","journal-title":"Eur J Pharmacol"},{"key":"477_CR223","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-8993(99)01228-7","volume":"826","author":"U W\u00fcllner","year":"1999","unstructured":"W\u00fcllner U, Seyfried J, Groscurth P et al (1999) Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 826:53\u201362. https:\/\/doi.org\/10.1016\/S0006-8993(99)01228-7","journal-title":"Brain Res"},{"key":"477_CR224","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/STROKEAHA.112.681700","volume":"44","author":"X Xiong","year":"2013","unstructured":"Xiong X, White RE, Xu L, Yang L, Sun X, Zou B, Pascual C, Sakurai T, Giffard RG, Xie X (2013) Mitigation of murine focal cerebral ischemia by the hypocretin\/orexin system is associated with reduced inflammation. Stroke 44:764\u2013770. https:\/\/doi.org\/10.1161\/STROKEAHA.112.681700","journal-title":"Stroke"},{"key":"477_CR225","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.bjp.0704851","volume":"137","author":"T Yamamoto","year":"2002","unstructured":"Yamamoto T, Nozaki-Taguchi N, Chiba T (2002) Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 137:170\u2013176. https:\/\/doi.org\/10.1038\/sj.bjp.0704851","journal-title":"Br J Pharmacol"},{"key":"477_CR226","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0304-3940(03)00716-X","volume":"347","author":"T Yamamoto","year":"2003","unstructured":"Yamamoto T, Saito O, Shono K, Aoe T, Chiba T (2003) Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett 347:183\u2013186. https:\/\/doi.org\/10.1016\/S0304-3940(03)00716-X","journal-title":"Neurosci Lett"},{"key":"477_CR227","doi-asserted-by":"publisher","first-page":"14213","DOI":"10.1523\/JNEUROSCI.2390-10.2010","volume":"30","author":"Z Yan","year":"2010","unstructured":"Yan Z, Khadra A, Li S, Tomi\u0107 M, Sherman A, Stojilkovic SS (2010) Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci 30:14213\u201314224. https:\/\/doi.org\/10.1523\/JNEUROSCI.2390-10.2010","journal-title":"J Neurosci"},{"key":"477_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110447","volume":"129","author":"WJ Zhang","year":"2020","unstructured":"Zhang WJ, Luo HL, Zhu ZM (2020) The role of P2X4 receptors in chronic pain: A potential pharmacological target. Biomed Pharmacother 129:110447. https:\/\/doi.org\/10.1016\/j.biopha.2020.110447","journal-title":"Biomed Pharmacother"},{"key":"477_CR229","doi-asserted-by":"publisher","unstructured":"Zhang XY, Yu L, Zhuang QX, Zhu JN, Wang JJ (2013) Central functions of the orexinergic system. Neurosci Bull 29:355\u2013365.\u00a0https:\/\/doi.org\/10.1007\/s12264-012-1297-4","DOI":"10.1007\/s12264-012-1297-4"},{"key":"477_CR230","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pain.2004.12.022","volume":"114","author":"ZY Zhuang","year":"2005","unstructured":"Zhuang ZY, Gerner P, Woolf CJ, Ji RR (2005) ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114:149\u2013159. https:\/\/doi.org\/10.1016\/j.pain.2004.12.022","journal-title":"Pain"},{"key":"477_CR231","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.jpain.2014.01.199","volume":"15","author":"H Xiang","year":"2014","unstructured":"Xiang H, Liu T, Tian X, Liu C (2014) (290) Possible mechanism of regulating glucose metabolism with subthalamic nucleus stimulation for intractable pain: a virally mediated trans-synaptic tracing study in transgenic mice. J Pain 15:S48. https:\/\/doi.org\/10.1016\/j.jpain.2014.01.199","journal-title":"J Pain"},{"key":"477_CR232","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF02255972","volume":"8","author":"T Zima","year":"2001","unstructured":"Zima T, Fialov\u00e1 L, Mestek O et al (2001) Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci 8:59\u201370. https:\/\/doi.org\/10.1007\/BF02255972","journal-title":"J Biomed Sci"},{"key":"477_CR233","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08830185.2020.1723582","volume":"39","author":"M Zyma","year":"2020","unstructured":"Zyma M, Pawliczak R (2020) Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response: Purinergic receptors are widely expressed in immune cells and regulate high variety of their functions, taking part in pathogenesis of many diseases. Int Rev Immunol 39:97\u2013117. https:\/\/doi.org\/10.1080\/08830185.2020.1723582","journal-title":"Int Rev Immunol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00477-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-022-00477-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00477-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T04:58:47Z","timestamp":1650689927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-022-00477-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":233,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1007\/s12640-022-00477-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All the authors have given approval for publication of the current manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of Potential Conflicts of Interest"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}